nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Aberrant induction of LMO2 by the E2A-HLF chimeric transcription factor and its implication in leukemogenesis of B-precursor ALL with t(17;19)
|
Hirose, Kinuko |
|
|
116 |
6 |
p. 962-970 |
artikel |
2 |
A Munc in the platelet granule works
|
Marks, Michael S. |
|
|
116 |
6 |
p. 864-865 |
artikel |
3 |
Another Lnk to STAT activation
|
Bunting, Kevin D. |
|
|
116 |
6 |
p. 862-864 |
artikel |
4 |
A novel prognostic model in elderly patients with acute myeloid leukemia: results of 909 patients entered into the prospective AML96 trial
|
Röllig, Christoph |
|
|
116 |
6 |
p. 971-978 |
artikel |
5 |
A phase 2 study of eliglustat tartrate (Genz-112638), an oral substrate reduction therapy for Gaucher disease type 1
|
Lukina, Elena |
|
|
116 |
6 |
p. 893-899 |
artikel |
6 |
A self-inactivating lentiviral vector for SCID-X1 gene therapy that does not activate LMO2 expression in human T cells
|
Zhou, Sheng |
|
|
116 |
6 |
p. 900-908 |
artikel |
7 |
CLL 17p deletion: more than 'miR'ly p53?
|
Zenz, Thorsten |
|
|
116 |
6 |
p. 859-860 |
artikel |
8 |
Complement inhibition decreases the procoagulant response and confers organ protection in a baboon model of Escherichia coli sepsis
|
Silasi-Mansat, Robert |
|
|
116 |
6 |
p. 1002-1010 |
artikel |
9 |
Comprehensive analysis of lymph node stroma-expressed Ig superfamily members reveals redundant and nonredundant roles for ICAM-1, ICAM-2, and VCAM-1 in lymphocyte homing
|
Boscacci, Rémy T. |
|
|
116 |
6 |
p. 915-925 |
artikel |
10 |
Differentiation of type 1 T regulatory cells (Tr1) by tolerogenic DC-10 requires the IL-10–dependent ILT4/HLA-G pathway
|
Gregori, Silvia |
|
|
116 |
6 |
p. 935-944 |
artikel |
11 |
Discovery of Hippo in MCL
|
Auer, Rebecca |
|
|
116 |
6 |
p. 861-862 |
artikel |
12 |
Editorial Board
|
|
|
|
116 |
6 |
p. i |
artikel |
13 |
Enhancing research in regenerative medicine
|
Williams, David A. |
|
|
116 |
6 |
p. 866-867 |
artikel |
14 |
Extracellular protein disulfide isomerase regulates coagulation on endothelial cells through modulation of phosphatidylserine exposure
|
Popescu, Narcis I. |
|
|
116 |
6 |
p. 993-1001 |
artikel |
15 |
Falini B, Macijewski K, Weiss T, et al. Multilineage dysplasia has no impact on biologic, clinicopathologic, and prognostic features of AML with mutated nucleophosmin (NPM1).
|
|
|
|
116 |
6 |
p. 1017 |
artikel |
16 |
Independently acquired biallelic JAK2 mutations are present in a minority of patients with essential thrombocythemia
|
Beer, Philip A. |
|
|
116 |
6 |
p. 1013-1014 |
artikel |
17 |
Live imaging of Runx1 expression in the dorsal aorta tracks the emergence of blood progenitors from endothelial cells
|
Lam, Enid Yi Ni |
|
|
116 |
6 |
p. 909-914 |
artikel |
18 |
Long-lasting antitumor protection by anti-CD20 antibody through cellular immune response
|
Abès, Riad |
|
|
116 |
6 |
p. 926-934 |
artikel |
19 |
Mahadeo KM, Cole PD. Successful treatment using omacetaxine for a patient with CML and BCR-ABL2 35INS [letter].
|
|
|
|
116 |
6 |
p. 1017 |
artikel |
20 |
microRNA fingerprinting of CLL patients with chromosome 17p deletion identify a miR-21 score that stratifies early survival
|
Rossi, Simona |
|
|
116 |
6 |
p. 945-952 |
artikel |
21 |
Moorman AV, Chilton L, Wilkinson J, Ensor HM, Bown N, Proctor SJ. A population-based cytogenetic study of adults with acute lymphoblastic leukemia.
|
|
|
|
116 |
6 |
p. 1017 |
artikel |
22 |
Munc13-4 is a limiting factor in the pathway required for platelet granule release and hemostasis
|
Ren, Qiansheng |
|
|
116 |
6 |
p. 869-877 |
artikel |
23 |
Myeloid-specific inactivation of p15Ink4b results in monocytosis and predisposition to myeloid leukemia
|
Bies, Juraj |
|
|
116 |
6 |
p. 979-987 |
artikel |
24 |
Novel mutations in the inhibitory adaptor protein LNK drive JAK-STAT signaling in patients with myeloproliferative neoplasms
|
Oh, Stephen T. |
|
|
116 |
6 |
p. 988-992 |
artikel |
25 |
Pathway discovery in mantle cell lymphoma by integrated analysis of high-resolution gene expression and copy number profiling
|
Hartmann, Elena M. |
|
|
116 |
6 |
p. 953-961 |
artikel |
26 |
Phase 2 and pharmacodynamic study of oral forodesine in patients with advanced, fludarabine-treated chronic lymphocytic leukemia
|
Balakrishnan, Kumudha |
|
|
116 |
6 |
p. 886-892 |
artikel |
27 |
Poor outcome after reintroduction of imatinib in patients with chronic myeloid leukemia who interrupt therapy on account of pregnancy without having achieved an optimal response
|
Kuwabara, Aya |
|
|
116 |
6 |
p. 1014-1016 |
artikel |
28 |
Population-based analyses in adult acute lymphoblastic leukemia
|
Juliusson, Gunnar |
|
|
116 |
6 |
p. 1011 |
artikel |
29 |
Rebalanced hemostasis in patients with liver disease: evidence and clinical consequences
|
Lisman, Ton |
|
|
116 |
6 |
p. 878-885 |
artikel |
30 |
Response: Age- and sex-adjusted incidence rates of adults with acute lymphoblastic leukemia (ALL) in the northern part of England
|
Moorman, Anthony V. |
|
|
116 |
6 |
p. 1012 |
artikel |
31 |
The substrate is down: is the IV out?
|
Szer, Jeff |
|
|
116 |
6 |
p. 860-861 |
artikel |